Literature DB >> 3632430

Improvement of the blood-retinal barrier induced by bendazac lysine: preliminary clinical observation in insulin-dependent diabetics.

G Nuzzi, I Venturini, M Bonacini, R Sarzi-Amadé.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3632430     DOI： 10.1001/archopht.1987.01060090023007

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  3 in total

1.  Permeability of the blood-retinal barrier in healthy humans. European Concerted Action on Ocular Fluorometry.

Authors:  H J Van Schaik; B Heintz; M Larsen; E Leite; V Rosas; R Schalnus; J A Van Best
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-10       Impact factor: 3.117

Review 2.  Bendazac lysine. A review of its pharmacological properties and therapeutic potential in the management of cataracts.

Authors:  J A Balfour; S P Clissold
Journal:  Drugs       Date:  1990-04       Impact factor: 9.546

3.  Effect of bendazac lysine on lens and retina in diabetics.

Authors:  J M Benitez del Castillo; I Jimenez-Alfaro; P Ortega; A Castillo; D Diaz; N Toledano; J Garcia-Sanchez
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.